Tower Research Capital (TRC)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.48K Buy
1,370
+1,218
+801% +$2.21K ﹤0.01% 4647
2025
Q1
$309 Buy
152
+136
+850% +$276 ﹤0.01% 4944
2024
Q4
$97 Sell
16
-671
-98% -$4.07K ﹤0.01% 5471
2024
Q3
$6.71K Sell
687
-68
-9% -$664 ﹤0.01% 4113
2024
Q2
$15.5K Buy
755
+466
+161% +$9.54K ﹤0.01% 3904
2024
Q1
$13K Sell
289
-576
-67% -$26K ﹤0.01% 3422
2023
Q4
$40.8K Buy
865
+610
+239% +$28.8K ﹤0.01% 3263
2023
Q3
$10.3K Sell
255
-100
-28% -$4.05K ﹤0.01% 4124
2023
Q2
$37.8K Buy
355
+259
+270% +$27.6K ﹤0.01% 2799
2023
Q1
$29K Buy
96
+65
+210% +$19.6K ﹤0.01% 3020
2022
Q4
$11K Sell
31
-47
-60% -$16.7K ﹤0.01% 3792
2022
Q3
$15K Sell
78
-86
-52% -$16.5K ﹤0.01% 4157
2022
Q2
$35K Sell
164
-43
-21% -$9.18K ﹤0.01% 3206
2022
Q1
$69K Sell
207
-86
-29% -$28.7K ﹤0.01% 2476
2021
Q4
$95K Hold
293
﹤0.01% 2254
2021
Q3
$143K Buy
293
+242
+475% +$118K ﹤0.01% 2099
2021
Q2
$23K Sell
51
-56
-52% -$25.3K ﹤0.01% 3751
2021
Q1
$74K Buy
107
+101
+1,683% +$69.9K ﹤0.01% 2810
2020
Q4
$4K Sell
6
-105
-95% -$70K ﹤0.01% 4688
2020
Q3
$77K Sell
111
-262
-70% -$182K ﹤0.01% 3328
2020
Q2
$316K Buy
373
+366
+5,229% +$310K 0.01% 1397
2020
Q1
$3K Buy
+7
New +$3K ﹤0.01% 2445
2019
Q4
Sell
-81
Closed -$9K 3575
2019
Q3
$9K Buy
81
+57
+238% +$6.33K ﹤0.01% 2981
2019
Q2
$4K Buy
+24
New +$4K ﹤0.01% 3009
2019
Q1
Sell
-70
Closed -$4K 3805
2018
Q4
$4K Buy
70
+50
+250% +$2.86K ﹤0.01% 3001
2018
Q3
$2K Buy
+20
New +$2K ﹤0.01% 3409
2018
Q2
Sell
-6
Closed -$1K 3656
2018
Q1
$1K Buy
+6
New +$1K ﹤0.01% 3048